MMC backs AI-powered Current Health, leading $11.5 million Series A

We are proud to be continuing our partnership with Chris, Stewart and the rest of the Current Health team as they announce their $11.5 million (£9 million) Series A funding round.

Current Health offers the leading FDA-cleared, AI-powered patient management platform which uses wearable and wireless vital signs monitoring, clinical indicators from an ecosystem of more than 50 integrations and symptoms collected via its patient engagement tools, to continuously track patient health trends. Leveraging proprietary machine learning algorithms, the company’s end-to-end platform analyses this data to proactively detect illness and alert providers to high-risk patients so they can deliver healthcare earlier.

Healthcare is undergoing a paradigm shift from reactive, in-hospital treatment to proactive, community-based care. Today’s healthcare systems must deliver improved patient outcomes while reducing costs. Current Health’s revolutionary solution offers unprecedented insight into patients’ health. Reliable, continuous patient monitoring enables earlier intervention in the event of patient deterioration, a better experience for patients and fewer unnecessary hospital re-admissions. With its world-class team and platform, Current Health has the right fundamentals to execute on a vast opportunity and become a global category leader in this important market.

BRUCE MACFARLANEMANAGING PARTNER, MMC

Today, 13 of the largest healthcare systems in the United States and United Kingdom – including Mount Sinai and Dartford & Gravesham NHS Trust– use Current Health to manage patient care. With the Current Health platform, customers have been able to shorten hospital stays, reduce hospital readmission rates, improve patient satisfaction and deliver better patient outcomes.

We’ve spent the last three years quietly and carefully building and testing our platform directly with healthcare providers. Now with our platform FDA-cleared and through partnerships with some of the biggest healthcare providers and pharmaceutical companies in the world, we plan to scale our solution to better treat millions of lives over the next five years. By helping healthcare providers treat patients preventively and at the earliest point, we can play a key role in enabling sustainable, high-quality and universal healthcare delivery.

CHRIS MCCANNCEO & FOUNDER, CURRENT HEALTH